QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

[PROBLEMS] To provide a compound having an excellent inhibitory effect on platelet aggregation. [MEANS FOR SOLVING PROBLEMS] Disclosed is a quinolone derivative having a lower alkyl, a cycloalkyl or the like at the 1-position;-N(R0)C(O)-lower alkylene-CO2R0, a lower alkylene-CO2R0, a lower alkenylen...

Full description

Saved in:
Bibliographic Details
Main Authors UEMURA TOSHIO, OKUDA TAKAO, MORITOMO HIROYUKI, FUJIYASU JIRO, TAKASAKI JUN, KAMIKUBO TAKASHI, KOGA YUJI, WATANUKI SUSUMU, HIRAYAMA FUKUSHI, KAGEYAMA MICHIHITO
Format Patent
LanguageEnglish
Published 19.12.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[PROBLEMS] To provide a compound having an excellent inhibitory effect on platelet aggregation. [MEANS FOR SOLVING PROBLEMS] Disclosed is a quinolone derivative having a lower alkyl, a cycloalkyl or the like at the 1-position;-N(R0)C(O)-lower alkylene-CO2R0, a lower alkylene-CO2R0, a lower alkenylene-CO2R0,-O-lower alkenylene-CO2R0,-O-(-lower alkylene which may be substituted by-CO2R0)-aryl,-O-lower alkenylene-CO2R0 (wherein R0 represents H or a lower alkyl) at the 3-position; a halogen at the 6-position; and an amino group substituted by a substituent having a cyclic structure at the 7-position, or a pharmaceutically acceptable salt thereof. It is found that the quinolone derivative has an excellent P2Y12Y-inhibiting effect. It is also found that the quinolone derivative has an excellent inhibitory effect on platelet aggregation. Therefore, the quinolone derivative or the pharmaceutically acceptable salt thereof is useful as a platelet aggregation inhibitor. ® KIPO & WIPO 2009
Bibliography:Application Number: KR20087025134